Gregory Reyes, Senior VP, Research at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 3,000 shares at $2.90 ($9K) on 2008-03-20, disclosed to the SEC on 2008-03-21.
Open-market purchase of $9k CYCC by Senior VP, Research. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.